Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
- 1 April 2017
- journal article
- Published by Elsevier in European Urology
- Vol. 71 (4) , 665-673
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersAmerican Journal of Surgical Pathology, 2013
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell CarcinomaEuropean Urology, 2013
- Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinomaBritish Journal of Cancer, 2012
- Development and evaluation of BioScoreCancer, 2009
- The ‘Stage, Size, Grade and Necrosis’ score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer‐specific survival in patients with clear cell renal cell carcinomaBJU International, 2008
- Renal cell cancer stage migrationCancer, 2008
- External Validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) Score to Predict Cancer Specific Survival Using a European Series of Conventional Renal Cell CarcinomaJournal of Urology, 2006
- Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressivenessCancer, 2005
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003
- An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign ScoreJournal of Urology, 2002